These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 8902408
1. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium. Bonilla HF, Perri MB, Kauffman CA, Zervos MJ. Diagn Microbiol Infect Dis; 1996 Jul; 25(3):127-31. PubMed ID: 8902408 [Abstract] [Full Text] [Related]
2. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents. Matsumura SO, Louie L, Louie M, Simor AE. Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762 [Abstract] [Full Text] [Related]
3. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Eliopoulos GM, Wennersten CB, Gold HS, Schülin T, Souli M, Farris MG, Cerwinka S, Nadler HL, Dowzicky M, Talbot GH, Moellering RC. Antimicrob Agents Chemother; 1998 May; 42(5):1088-92. PubMed ID: 9593132 [Abstract] [Full Text] [Related]
4. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. Kang SL, Rybak MJ. J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060 [Abstract] [Full Text] [Related]
5. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium. Hill RL, Smith CT, Seyed-Akhavani M, Casewell MW. J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058 [Abstract] [Full Text] [Related]
6. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations. Aeschlimann JR, Zervos MJ, Rybak MJ. Antimicrob Agents Chemother; 1998 Oct; 42(10):2710-7. PubMed ID: 9756782 [Abstract] [Full Text] [Related]
7. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium. Wang FD, Liu IM, Liu CY. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922 [Abstract] [Full Text] [Related]
8. Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci. Eliopoulos GM, Wennersten CB. Antimicrob Agents Chemother; 2002 May; 46(5):1319-24. PubMed ID: 11959562 [Abstract] [Full Text] [Related]
9. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)]. Betriu C, Valverde JF, Culebras E, Gómez M, Sánchez A, Palau ML, Picazo JJ. Enferm Infecc Microbiol Clin; 1999 May; 17(7):335-9. PubMed ID: 10535185 [Abstract] [Full Text] [Related]
10. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium. Lorian V, Fernandes F. Drugs Exp Clin Res; 1998 May; 24(2):73-6. PubMed ID: 9675547 [Abstract] [Full Text] [Related]
11. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases. Dever LL, Smith SM, Dejesus D, Masurekar M, Patel D, Kaminski ZC, Johanson WG. Microb Drug Resist; 1996 May; 2(4):407-13. PubMed ID: 9158811 [Abstract] [Full Text] [Related]
13. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort. Linden PK, Pasculle AW, McDevitt D, Kramer DJ. J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079 [Abstract] [Full Text] [Related]
14. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Bozdogan B, Leclercq R. Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753 [Abstract] [Full Text] [Related]
15. [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates]. Gülden E, Ermertcan S. Mikrobiyol Bul; 2009 Jan; 43(1):53-60. PubMed ID: 19334380 [Abstract] [Full Text] [Related]
16. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. Moellering RC, Linden PK, Reinhardt J, Blumberg EA, Bompart F, Talbot GH. J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233 [Abstract] [Full Text] [Related]
17. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. McDonald LC, Rossiter S, Mackinson C, Wang YY, Johnson S, Sullivan M, Sokolow R, DeBess E, Gilbert L, Benson JA, Hill B, Angulo FJ. N Engl J Med; 2001 Oct 18; 345(16):1155-60. PubMed ID: 11642231 [Abstract] [Full Text] [Related]
18. Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium. Lorian V, Fernandes F. J Antimicrob Chemother; 1997 May 18; 39 Suppl A():63-6. PubMed ID: 9511065 [Abstract] [Full Text] [Related]